Diseases & Conditions Market Research Reports & Industry Analysis
Insomnia is a common condition in which one has trouble going to sleep or staying asleep. This condition can range from weak to strong, depending on how often it occurs and for how long. Insomnia can be ongoing or acute. Chronic insomnia means having symptoms at least 3 nights a week for more than a month. Acute insomnia lasts for less time. Some people who have insomnia will have trouble falling asleep. Other people may fall asleep easily but, then wake up.
Diseases & Conditions Industry Research & Market Reports
-
Pharmaceutical Manufacturing Market Size, Share, and Outlook, 2025 Report- By Molecule (Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules)), By Drug Development (In-house, Outsource), By Formulation (Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Others), By Route of Administration (Oral, Topical, Parenteral, Inhalations, Others), By Therapy Area (Cardiovascular Diseases, Pain, Diabetes, Cancer, Respiratory Diseases, Others), By Prescription (Prescription Medicines, Over-the-counter (OTC) Medicines), By Age group (Children & Adolescents, Adults, Geriatric), By Sales Channel (Retail, Non-retail), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Pharmaceutical Manufacturing segments across 22 countries from 2021 to 2032. ... Read More
-
Single Use Ophthalmic Surgical Devices Market Size, Share, and Outlook, 2025 Report- By Product (Forceps, Speculum, Nucleus Rotators & Choppers, Curettes, Cannulas, Knives, OVD, Others), By Application (Diabetic Retinopathy, Cataract Surgery, Glaucoma Surgery, Refractive Surgery, Corneal Surgery, Vitreo-Retinal Surgery, Others), By End-user (Hospitals, Ophthalmic clinic, ASCs, Others), 2021-2032
... is a thriving business that is poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Single ... Read More
-
In-vitro Diagnostics Enzymes Market Size, Share, and Outlook, 2025 Report- By Type (Proteases, Polymerase & Transcriptase, Ribonuclease, Others), By Disease , Infectious disease, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune diseases, Others), By Technology (Histology Assays, Molecular Diagnostics, -PCR Assays, -NGS Assays, -Others), Clinical Chemistry), By End-user (Pharma & Biotech, Hospital & Diagnostic Labs, Contract Research Organizations (CROs), Academic Labs, 2021-2032
... poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on In-vitro Diagnostics Enzymes segments across 22 countries ... Read More
-
Tumor Necrosis Factor Inhibitor Drugs Market Size, Share, and Outlook, 2025 Report- By Product (Humira, Enbrel, Remicade, Simponi/Simponi Aria, Cimzia, Biosimilars), By Application (Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, Crohn’s Disease, Ulcerative Colitis, Ankylosing Spondylitis, Juvenile Idiopathic Arthritis, Hidradenitis Suppurativa, Others), By Sales Channel (Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies), 2021-2032
... is a thriving business that is poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Tumor ... Read More
-
Targeted DNA RNA Sequencing Market Size, Share, and Outlook, 2025 Report- By Technology (NGS By Method (Exome Sequencing, Enrichment Sequencing, Amplicon Sequencing), NGS By Application (Cancer Gene Sequencing, Inherited Disease Screening, Drug Development, Forensic Genomics, 16S ribosomal RNA (rRNA) sequencing, Others)), By Workflow (Pre-sequencing, Sequencing, Data Analysis), By Application (Human Biomedical Research, Plant & Animal Sciences, Drug Discovery, Others), By Type (DNA Based Targeted Sequencing, RNA Based Targeted Sequencing), By End-user (Academic Research, Hospitals & Clinics, Pharma & Biotech Entities, Others), 2021-2032
... business that is poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Targeted DNA RNA Sequencing ... Read More
-
Fabry Disease Treatment Market Size, Share, and Outlook, 2025 Report- By Treatment (Enzyme Replacement Therapy, Oral Chaperone Therapy, Others), By Route of Aministration, Oral Route, Intravenous Route), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), 2021-2032
... poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Fabry Disease Treatment segments across 22 countries ... Read More
-
Veterinary Intravenous (IV) Solutions Market Size, Share, and Outlook, 2025 Report- By Product (Isotonic crystalloids, Synthetic colloids, Blood products, Dextrose solutions, Parenteral nutrition), By Indication (Diabetic Ketoacidosis, Pancreatitis, Anthrax, Chronic Kidney Disease, Others), By Animal Type (Companion Animals, Production Animals), By End-user (Veterinary Hospitals, Research Institutes, Others), 2021-2032
... business that is poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Veterinary Intravenous (IV) Solutions ... Read More
-
Neurorehabilitation Devices Market Size, Share, and Outlook, 2025 Report- By Product (Neurorobotics, Brain-Computer Interface, Wearable Devices, Non-Invasive Stimulators, Others), By Therapy Area (Stroke, Parkinson’s Disease, Multiple Sclerosis, Cerebral Palsy, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Neurorehabilitation Devices segments across 22 countries from 2021 to 2032. ... Read More
-
mRNA Therapeutics Contract Development & Manufacturing Market Size, Share, and Outlook, 2025 Report- By Application (Viral Vaccines, Protein Replacement Therapies, Cancer Immunotherapies), By Indication (Infectious Diseases, Metabolic & Genetic Diseases, Cardiovascular & Cerebrovascular Diseases), By End-user (Biotech Companies, Pharmaceutical companies, Government & Academic Research Institutes), 2021-2032
... & Manufacturing market is a thriving business that is poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast ... Read More
-
Plasmid DNA Manufacturing Market Size, Share, and Outlook, 2025 Report- By Grade (R&D Grade, GMP Grade), By Development Phase (Pre-Clinical Therapeutics, Clinical Therapeutics, Marketed Therapeutics), By Application (DNA Vaccines, Cell & Gene Therapy, Immunotherapy, Others), By Disease (Infectious Disease, Cancer, Genetic Disorder, Others), 2021-2032
... poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Plasmid DNA Manufacturing segments across 22 countries ... Read More
-
Neglected Tropical Diseases Drugs And Vaccines Market Size, Share, and Outlook, 2025 Report- By Disease (Malaria, Ebola, Dengue, Chagas, Leishmaniasis, Zika Virus), By Product (Drugs, Vaccines), 2021-2032
... And Vaccines market is a thriving business that is poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast ... Read More
-
Enzyme Replacement Therapy Market Size, Share, and Outlook, 2025 Report- By Product (Agalsidase Beta, Imiglucerase , Velaglucerase Alfa, Idursulfase, Galsulfase, Laronidase, Others), By Disease (Gaucher Disease, Fabry Disease, Pompe Disease, Mucopolysaccharidosis, Exocrine Pancreatic Insufficiency (EPI), Others), By End-User (Hospitals, Infusion Centers & Home Healthcare Setting), 2021-2032
... poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Enzyme Replacement Therapy segments across 22 countries ... Read More
-
Neglected Tropical Disease Treatment Market Size, Share, and Outlook, 2025 Report- By Disease (Dengue, Rabies, Trachoma, Buruli ulcer, Yaws, Leprosy, Chagas disease, Human African trypanosomiasis, Leishmaniases, Soil-transmitted helminthiases, Others), By Product (Drugs, Vaccines), 2021-2032
... business that is poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Neglected Tropical Disease Treatment ... Read More
-
Advanced Cancer Diagnostics Market Size, Share, and Outlook, 2025 Report- By Type (Genomics Based, Epigenomics Based, Proteomics Based, Cellular Analysis Based), 2021-2032
... poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Advanced Cancer Diagnostics segments across 22 countries ... Read More
-
Immunoassay for Neurological Biomarkers Market Size, Share, and Outlook, 2025 Report- By Product (Instruments, Reagents, Services), By Disease (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Others), By Application (In Vitro Diagnostics Application, Research Application), 2021-2032
... business that is poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Immunoassay for Neurological Biomarkers ... Read More
-
Neurological Biomarkers Market Size, Share, and Outlook, 2025 Report- By Type (Genomic, Proteomic, Metabolomic, Imaging, Others), By Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorder, Others), By End-user (Hospital & Hospital Laboratories, Independent clinical diagnostic centers, Research Organizations, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Neurological Biomarkers segments across 22 countries from 2021 to 2032. ... Read More
-
Active Wheelchair Market Size, Share, and Outlook, 2025 Report- By Product (Manual Wheelchairs, Power Wheelchairs), By Indication (Alzheimer’s Disease, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis, Diabetes, Cerebral Palsy, Muscular Dystrophy, Parkinson’s Disease, Scoliosis, Spina Bifida, Spinal Cord Injury, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Active Wheelchair segments across 22 countries from 2021 to 2032. ... Read More
-
Continence Care Market Size, Share, and Outlook, 2025 Report- By Product (Urinary Catheters, Catheter Maintenance/Care, Urinary Bags), By Application (Diabetes, Strokes, BPH, Alzheimer, Cerebral Palsy, Parkinson, Prostate cancer, Spinal Cord Injury, Bladder Cancer, Multiple sclerosis, Spina Bifida, Others), By Bag Usage, Sterile bags, Non-sterile bags), By End-User (Home Care Settings, Hospitals, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Continence Care segments across 22 countries from 2021 to 2032. ... Read More
-
Biopharmaceuticals Contract Manufacturing Market Size, Share, and Outlook, 2025 Report- By Source (Mammalian, Non-mammalian), By Service (Process Development, Fill & Finish Operations, Analytical & QC studies, Packaging), By Product (Biologics, BiosimilarsOthers), By Therapeutic Area (Oncology, Autoimmune Diseases, Metabolic Diseases, Cardiovascular Diseases, Neurology, Infectious Diseases, Others), 2021-2032
... poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Biopharmaceuticals Contract Manufacturing segments across 22 countries ... Read More
-
Erythropoietin Drugs Market Size, Share, and Outlook, 2025 Report- By Type (Biologics, Biosimilars), By Product (Erythropoietin, Darbepoetin-alfa), By Application (Cancer, Renal Diseases, Neurology, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Erythropoietin Drugs segments across 22 countries from 2021 to 2032. ... Read More
-
Neurometabolic Disorders Market Size, Share, and Outlook, 2025 Report- By Types (Fabry disease, Niemann-pick Type C Disease, Gaucher's Disease, Pompe Disease, Mucopolysaccharidosis VI), By Route of Administration (Parenteral, Oral), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Neurometabolic Disorders segments across 22 countries from 2021 to 2032. ... Read More
-
Pharmaceutical Market Size, Share, and Outlook, 2025 Report- By Molecule (Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules), Pharmaceutical Product, Branded, Generic), By Type (Prescription, OTC, Pharmaceutical Disease, Cardiovascular diseases, Cancer, Diabetes, Infectious diseases, Neurological disorders, Respiratory, Autoimmune, Mental health disorders, Gastrointestinal disorders, Women’s health Diseases, Genetic and rare genetic diseases, Dermatological conditions, Obesity, Renal diseases, Liver conditions, Hematological disorders, Others), By Route of Administration (Oral, Topical, Parenteral, Other), By Formulation (Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Others), By Age group (Children & Adolescents, Adults, Geriatric), By End-user (Hospitals, Clinics, Others), 2021-2032
... potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Pharmaceutical segments across 22 countries from 2021 to 2032. Key segments in the ... Read More
-
Gaucher Disease Drugs Market Size, Share, and Outlook, 2025 Report- By Type (Type 1, Type 2, Type 3, Others), By Drugs (Enzyme Replacement Therapy, Substrate Replacement Therapy, Others), 2021-2032
... poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Gaucher Disease Drugs segments across 22 countries ... Read More
-
Deep Brain Stimulation in Parkinson's Disease Market Size, Share, and Outlook, 2025 Report- By Product (Single Channel, Dual Channel), By End-User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers), 2021-2032
... Parkinson's Disease market is a thriving business that is poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast ... Read More
-
Tumor Profiling Market Size, Share, and Outlook, 2025 Report- By Cancer (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, Others), By Biomarker, Genomic Biomarker, Protein Biomarker), By Technology (Immunoassays, Next-Generation Sequencing, Polymerase Chain Reaction, Mass Spectrometry, In-Situ Hybridization, Microarrays, Others), By Technique (Genomics, Proteomics, Metabolomics, Epigenetics), By Application (Research, Biomarker Discovery, Personalized Medicine, Clinical Application, Diagnostics, Prognostics, Screening, Treatment and Monitoring), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Tumor Profiling segments across 22 countries from 2021 to 2032. ... Read More